drugset / Trial / NCT00698802

Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 Diabetes

NCT00698802

Phase 2 Completed 397 enrolled Novo Nordisk A/S
RandomizedParallel-groupOpen-labelTreatment

Summary

This trial is conducted in Asia and Africa. This trial aims for a comparison of blood glucose control of biphasic human insulin 100 IU/mL and EX1000.

Timeline

Start
2008-06
Primary completion
2009-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject EX1000 Unknown Subcutaneous
Comparator biphasic human insulin Protein / enzyme biologic Subcutaneous